Evidence map›Paper›PMID 21196358›Full record

ReviewFrontiers in bioscience (Scholar edition)2011

Adipose tissue as a stem cell source for musculoskeletal regeneration.

Jeffrey M Gimble, Warren Grayson, Farshid Guilak, Mandi J Lopez, Gordana Vunjak-Novakovic

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience (Scholar edition), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Osteochondral tissue engineering approaches for articular cartilage and subchondral bone regeneration.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2012
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  7. Immunomodulatory Effects of MSCs in Bone Healing.International journal of molecular sciences · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies.Archivum immunologiae et therapiae experimentalis · 2016
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Stem cell technology for bone regeneration: current status and potential applications.Stem cells and cloning : advances and applications · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jeffrey M GimblePennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA. gimblejm@pbrc.edu
Warren Grayson
Farshid Guilak
Mandi J Lopez
Gordana Vunjak-Novakovic
Pennington Biomedical Research Center · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
Craniofacial Tissue EngineeringR01DE016525 · NIDCR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2005 to 2017
$5.5M
Mechanical and Osmotic Signaling in ChondrocytesR01AR048182 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2013
$3.0M
Intrinsic Repair of the Knee MeniscusR01AR048852 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2007 to 2011
$1.4M
ADULT STEM CELL SUPPRESSION DUE TO ALCOHOL INDUCED MICROENVIRONMENT ALTERATIONSR15AA017546 · NIAAA · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI LOPEZ, MANDI J. · 2008 to 2010
$268k
NIAAA NIH HHS R15AA017546NIAMS NIH HHS AR48182NIAMS NIH HHS AR48852NIAMS NIH HHS AR50245NIAMS NIH HHS P01 AR050245NIAMS NIH HHS R01 AR048182NIAMS NIH HHS R01 AR048852NIA NIH HHS AG15768NIA NIH HHS R01 AG015768NIBIB NIH HHS 2P41-EB002520NIBIB NIH HHS P41 EB002520NIDCR NIH HHS R01 DE016525NIDCR NIH HHS R01DE16525
6 · The paper itself

Abstract

Adipose tissue is an abundant, easily accessible, and reproducible cell source for musculo-skeletal regenerative medicine applications. Initial derivation steps yield a heterogeneous population of cells of stromal vascular fraction (SVF) cells. Subsequent adherent selection of the SVF results in a relatively homogeneous population of adipose-derived stromal/stem cells (ASCs) capable of adipogenic, chondrogenic, myogenic, and osteogenic differentiation in vitro on scaffolds in bioreactors and in vivo in pre-clinical animal models. Unlike hematopoietic cells, ASCs do not elicit a robust lymphocyte reaction and instead release immunosuppressive factors, such as prostaglandin E2. These immunomodulatory features suggest that allogeneic and autologous ASCs will engraft successfully for tissue regeneration purposes. The differentiation and expansion potential of ASCs can be modified by growth factors, bio-inductive scaffolds, and bioreactors providing environmental control and biophysical stimulation. Gene therapy approaches using lentiviral transduction can be used to direct differentiation of ASCs to particular lineages. We discuss the utility of ASCs for musculo-skeletal tissue repair and some of the technologies that can be implemented to unlock the full regenerative potential of these highly valuable cells.

Indexed as

Adipose TissueCell DifferentiationCell SeparationDinoprostoneGenetic TherapyHumansMusculoskeletal DevelopmentRegenerationStem CellsStem Cell TransplantationStromal CellsTissue EngineeringDinoprostone

Identifiers

PMID21196358
PMCPMC3636575
OpenAlexW1588232454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.